Rezolute (RZLT) Total Current Liabilities (2011 - 2026)
Rezolute (RZLT) posted Total Current Liabilities of $7.7 million for Q1 2026, down 19.19% sequentially from $9.5 million in Q4 2025, and down 26.67% YoY from $10.5 million in Q1 2025.
Analysis
Rezolute (RZLT) Total Current Liabilities (2011 - 2026) Analysis & Trends
Rezolute has reported Total Current Liabilities for 16 years, with the latest figure at $7.7 million in Q1 2026.
- Quarterly Total Current Liabilities fell 26.67% year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (down 26.67% YoY) and the FY2025 annual result came in at $11.9 million, up 24.01% from the prior year.
- Total Current Liabilities fell to $7.7 million in Q1 2026 per RZLT's latest filing, from $9.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $11.9 million in Q2 2025 and troughed at $2.4 million in Q3 2022.
- A 5-year average of $7.3 million and a median of $7.7 million in 2026 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities jumped 200.0% in 2023, then dropped 26.67% in 2026.
- Over 5 years, Total Current Liabilities stood at $6.3 million in 2022, then advanced by 27.11% to $8.0 million in 2023, then jumped by 32.37% to $10.6 million in 2024, then fell by 10.1% to $9.5 million in 2025, then fell by 19.19% to $7.7 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $7.7 million, $9.5 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | 7.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Sep 30, 2025 | 10.21 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Mar 31, 2025 | 10.53 Mn |
| Dec 31, 2024 | 10.61 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 9.61 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 6.45 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 1.97 Mn |